Surgically Induced Astigmatism of Temporal Versus Nasal Clear Corneal Phacoemulsification
Study Details
Study Description
Brief Summary
To compare the short-term astigmatic outcomes of phacoemulsification cataract surgery and intraocular lens implantation using temporal versus nasal clear corneal incisions.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
In a clinical trial, consecutive eyes with senile cataract underwent phacoemulsification with implantation of a 6.0 mm foldable hydrophobic acrylic intraocular lens through a 3.2 mm horizontal clear cornea incision at 180 degrees (temporal incision in right eyes, nasal incision in left eyes). Keratometric astigmatism was measured preoperatively and one and four weeks and 6 months after surgery. Surgically induced astigmatism (SIA) was calculated by the vector analysis method using the Holladay-Cravy-Koch formula. Patients with history of diabetes mellitus, connective tissue disorders, steroid use, previous ocular surgery, with the rule astigmatism >1D, pseudoexfoliation and any corneal pathology were excluded.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: 1 Temporal (right eye) |
Procedure: phacoemulsification and intraocular lens implantation
clear cornea phacoemulsification and intraocular lens implantation using temporal or nasal incisions respectively
|
Experimental: 2 Nasal (Left eye) |
Procedure: phacoemulsification and intraocular lens implantation
clear cornea phacoemulsification and intraocular lens implantation using temporal or nasal incisions respectively
|
Outcome Measures
Primary Outcome Measures
- Total and Surgical Induced Astigmatism [At 1 and 4 weeks and 6 month after surgery]
Eligibility Criteria
Criteria
Inclusion Criteria:
- All the patients with senile cataract
Exclusion Criteria:
-
Previously operated eyes
-
Presence of corneal pathology
-
Pseudo exfoliation
-
With-the-rule (WTR) astigmatism >1 D
-
Presence of diabetes mellitus
-
History of connective tissue disease
-
Consumption of systemic steroids
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Ophthalmic research center | Tehran | Iran, Islamic Republic of | 16666 |
Sponsors and Collaborators
- Shahid Beheshti University of Medical Sciences
Investigators
- Principal Investigator: Mohammad Pakravan, MD, Shahid Beheshti University of Medical Sciences
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 8380